BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 27638352)

  • 1. MLL3/MLL4/COMPASS Family on Epigenetic Regulation of Enhancer Function and Cancer.
    Sze CC; Shilatifard A
    Cold Spring Harb Perspect Med; 2016 Nov; 6(11):. PubMed ID: 27638352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The MLL3/MLL4 branches of the COMPASS family function as major histone H3K4 monomethylases at enhancers.
    Hu D; Gao X; Morgan MA; Herz HM; Smith ER; Shilatifard A
    Mol Cell Biol; 2013 Dec; 33(23):4745-54. PubMed ID: 24081332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The MLL3/4 H3K4 methyltransferase complex in establishing an active enhancer landscape.
    Wang LH; Aberin MAE; Wu S; Wang SP
    Biochem Soc Trans; 2021 Jun; 49(3):1041-1054. PubMed ID: 34156443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UTX and MLL4 coordinately regulate transcriptional programs for cell proliferation and invasiveness in breast cancer cells.
    Kim JH; Sharma A; Dhar SS; Lee SH; Gu B; Chan CH; Lin HK; Lee MG
    Cancer Res; 2014 Mar; 74(6):1705-17. PubMed ID: 24491801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancer-associated H3K4 monomethylation by Trithorax-related, the Drosophila homolog of mammalian Mll3/Mll4.
    Herz HM; Mohan M; Garruss AS; Liang K; Takahashi YH; Mickey K; Voets O; Verrijzer CP; Shilatifard A
    Genes Dev; 2012 Dec; 26(23):2604-20. PubMed ID: 23166019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancer malfunction in cancer.
    Herz HM; Hu D; Shilatifard A
    Mol Cell; 2014 Mar; 53(6):859-66. PubMed ID: 24656127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutant p53 regulates enhancer-associated H3K4 monomethylation through interactions with the methyltransferase MLL4.
    Rahnamoun H; Hong J; Sun Z; Lee J; Lu H; Lauberth SM
    J Biol Chem; 2018 Aug; 293(34):13234-13246. PubMed ID: 29954944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A UTX-MLL4-p300 Transcriptional Regulatory Network Coordinately Shapes Active Enhancer Landscapes for Eliciting Transcription.
    Wang SP; Tang Z; Chen CW; Shimada M; Koche RP; Wang LH; Nakadai T; Chramiec A; Krivtsov AV; Armstrong SA; Roeder RG
    Mol Cell; 2017 Jul; 67(2):308-321.e6. PubMed ID: 28732206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural insights into trans-histone regulation of H3K4 methylation by unique histone H4 binding of MLL3/4.
    Liu Y; Qin S; Chen TY; Lei M; Dhar SS; Ho JC; Dong A; Loppnau P; Li Y; Lee MG; Min J
    Nat Commun; 2019 Jan; 10(1):36. PubMed ID: 30604749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct kinetic mechanisms of H3K4 methylation catalyzed by MLL3 and MLL4 core complexes.
    Zheng Y; Huang Y; Mencius J; Li Y; Zhao L; Luo W; Chen Y; Quan S
    J Biol Chem; 2021; 296():100635. PubMed ID: 33823156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. H3.3K4M destabilizes enhancer H3K4 methyltransferases MLL3/MLL4 and impairs adipose tissue development.
    Jang Y; Broun A; Wang C; Park YK; Zhuang L; Lee JE; Froimchuk E; Liu C; Ge K
    Nucleic Acids Res; 2019 Jan; 47(2):607-620. PubMed ID: 30335158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. UTX Mutations in Human Cancer.
    Wang L; Shilatifard A
    Cancer Cell; 2019 Feb; 35(2):168-176. PubMed ID: 30753822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy.
    Wang L; Zhao Z; Ozark PA; Fantini D; Marshall SA; Rendleman EJ; Cozzolino KA; Louis N; He X; Morgan MA; Takahashi YH; Collings CK; Smith ER; Ntziachristos P; Savas JN; Zou L; Hashizume R; Meeks JJ; Shilatifard A
    Nat Med; 2018 Jun; 24(6):758-769. PubMed ID: 29785026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of the histone H3 lysine 4 methyltransferase MLL4 and the histone H3 lysine 27 demethylase UTX prolonging the overall survival of patients with glioblastoma and a methylated MGMT promoter.
    Kim J; Lee SH; Jang JH; Kim MS; Lee EH; Kim YZ
    J Neurosurg; 2017 May; 126(5):1461-1471. PubMed ID: 27367247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancer priming by H3K4 methyltransferase MLL4 controls cell fate transition.
    Wang C; Lee JE; Lai B; Macfarlan TS; Xu S; Zhuang L; Liu C; Peng W; Ge K
    Proc Natl Acad Sci U S A; 2016 Oct; 113(42):11871-11876. PubMed ID: 27698142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. H3K4 mono- and di-methyltransferase MLL4 is required for enhancer activation during cell differentiation.
    Lee JE; Wang C; Xu S; Cho YW; Wang L; Feng X; Baldridge A; Sartorelli V; Zhuang L; Peng W; Ge K
    Elife; 2013 Dec; 2():e01503. PubMed ID: 24368734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone H3 lysine 4 methyltransferase KMT2D.
    Froimchuk E; Jang Y; Ge K
    Gene; 2017 Sep; 627():337-342. PubMed ID: 28669924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mll3 and Mll4 Facilitate Enhancer RNA Synthesis and Transcription from Promoters Independently of H3K4 Monomethylation.
    Dorighi KM; Swigut T; Henriques T; Bhanu NV; Scruggs BS; Nady N; Still CD; Garcia BA; Adelman K; Wysocka J
    Mol Cell; 2017 May; 66(4):568-576.e4. PubMed ID: 28483418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activating signal cointegrator-2 is an essential adaptor to recruit histone H3 lysine 4 methyltransferases MLL3 and MLL4 to the liver X receptors.
    Lee S; Lee J; Lee SK; Lee JW
    Mol Endocrinol; 2008 Jun; 22(6):1312-9. PubMed ID: 18372346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone H3 lysine 4 monomethylation modulates long-range chromatin interactions at enhancers.
    Yan J; Chen SA; Local A; Liu T; Qiu Y; Dorighi KM; Preissl S; Rivera CM; Wang C; Ye Z; Ge K; Hu M; Wysocka J; Ren B
    Cell Res; 2018 Feb; 28(2):204-220. PubMed ID: 29313530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.